Disease-related variables | Hazard ratio | LCL | UCL | p Value |
Hypertension | ||||
Steroids used since last visit | 1.98 | 1.01 | 3.88 | 0.05 |
Interaction of steroids and calendar time | 1.69 | 0.86 | 3.31 | 0.13 |
Diabetes | 2.42 | 1.01 | 5.83 | 0.05 |
Logarithm of triglycerides | 1.43 | 1.11 | 1.86 | 0.01 |
PASI score (base category 0) | 0.03 | |||
0<PASI⩽10 | 0.83 | 0.41 | 1.71 | |
10<PASI⩽20 | 0.73 | 0.27 | 1.94 | |
PASI >20 | 2.12 | 0.87 | 5.20 | |
Unknown PASI | 0.65 | 0.25 | 1.71 | |
Myocardial infarction | ||||
ESR | 1.01 | 0.99 | 1.04 | 0.29 |
Interaction of ESR and gender | 1.01 | 0.97 | 1.04 | 0.74 |
Interaction of ESR and calendar time | 1.02 | 1.00 | 1.04 | 0.05 |
Interaction of ESR, gender and calendar time | 0.98 | 0.95 | 1.00 | 0.04 |
Current smoker | ||||
Yes | 9.09 | 1.93 | 42.76 | 0.01 |
Unknown | 2.35 | 0.70 | 7.88 | 0.17 |
Logarithm of triglycerides | 1.49 | 1.01 | 2.19 | 0.04 |
First CVD event | ||||
Steroids used since last visit | 1.78 | 0.96 | 3.31 | 0.07 |
Interaction of steroids and calendar time | 1.70 | 0.90 | 3.20 | 0.10 |
Diabetes | 2.10 | 1.00 | 4.43 | 0.05 |
Logarithm of triglycerides | 1.47 | 1.17 | 1.83 | <0.01 |
PASI score (base category = 0) | 0.05 | |||
0<PASI⩽10 | 1.28 | 0.61 | 2.69 | |
10<PASI⩽20 | 0.88 | 0.35 | 2.24 | |
PASI >20 | 2.71 | 1.13 | 6.51 | |
Unknown PASI | 1.45 | 0.50 | 4.19 | |
Interaction of PASI score and calendar time | 0.05 | |||
0<PASI⩽10 | 0.53 | 0.28 | 0.98 | |
10<PASI< = 20 | 0.67 | 0.20 | 2.32 | |
PASI >20 | 0.97 | 0.32 | 2.94 | |
Unknown PASI | 1.51 | 0.75 | 3.02 |
CVD, cardiovascular disease; ESR, erythrocyte sedimentation rate; LCL, lower 95% confidence limit; PASI, Psoriasis Area and Severity Index; UCL, upper 95% confidence limit.